Literature DB >> 12475823

Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study.

Olivier Vignaux1, Robin Dhote, Denis Duboc, Philippe Blanche, Daniel Dusser, Simon Weber, Paul Legmann.   

Abstract

PURPOSE: To assess the follow-up of patients with sarcoidosis and myocardial MRI abnormalities.
MATERIALS AND METHODS: Twelve patients with histologically proven sarcoidosis and highly suspected cardiac involvement underwent initial and 12-month follow-up cardiac assessment including cardiac MRI (T2-weighted, functional gradient echo, and T1-weighted gadolinium-diethylenetriamine penta-acetic acid-enhanced sequences). MRI abnormalities and clinical and MRI progression were scored by two observers.
RESULTS: Six patients receiving corticosteroid therapy (including three patients with clinical cardiac involvement) were scored as having cleared or improved at MRI follow-up, while others were seen to have worsened or remained stable. The stability, improvement, or clearing of MRI findings were correlated with clinically stable, improved or cleared sarcoidosis, while a worsening at MRI follow-up was correlated with a worsening of sarcoidosis and, in one patient, was predictive of clinical cardiac involvement.
CONCLUSION: Cardiac MRI is a useful noninvasive method for the early diagnosis and follow-up of cardiac sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475823     DOI: 10.1378/chest.122.6.1895

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  50 in total

Review 1.  Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease.

Authors:  M Francone; I Carbone; L Agati; C Bucciarelli Ducci; M Mangia; I Iacucci; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

Review 2.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

Review 3.  Delayed Myocardial Enhancement in Cardiac Magnetic Resonance Imaging.

Authors:  Arie Franco; Saeed Javidi; Stefan G Ruehm
Journal:  J Radiol Case Rep       Date:  2015-06-30

Review 4.  Clinical applications of cardiovascular magnetic resonance imaging.

Authors:  Constantin B Marcu; Aernout M Beek; Albert C van Rossum
Journal:  CMAJ       Date:  2006-10-10       Impact factor: 8.262

Review 5.  Current and upcoming roles of CT and MRI in clinical cardiac imagery.

Authors:  Scott Beach; Mushabbar A Syed
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

6.  Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis.

Authors:  B Borchert; T Lawrenz; M Bartelsmeier; S Röthemeyer; H Kuhn; C Stellbrink
Journal:  Clin Res Cardiol       Date:  2007-08-21       Impact factor: 5.460

Review 7.  Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging.

Authors:  Y Allanore; O Vignaux; L Arnaud; X Puéchal; S Pavy; D Duboc; P Legmann; A Kahan
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

8.  Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis.

Authors:  Seref Kul; Hatice Kutbay Ozcelik; Huseyin Uyarel; Gultekin Karakus; Tolga Sinan Guvenc; Murat Yalcınsoy; Emin Asoglu; Ahu Sarbay Kemik; Abdurrahman Tasal; Sinem Gungor; Ercan Karaarslan; Levent Kart; Omer Goktekin
Journal:  Lung       Date:  2014-04-29       Impact factor: 2.584

9.  Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Authors:  Aggeliki Rapti; Vasileios Kouranos; Elias Gialafos; Konstantina Aggeli; John Moyssakis; Anastasios Kallianos; Charalampos Kostopoulos; Ourania Anagnostopoulou; Petros P Sfikakis; Athol U Wells; George E Tzelepis
Journal:  Lung       Date:  2012-12-11       Impact factor: 2.584

10.  [MRI in cardiac sarcoidosis and amyloidosis].

Authors:  K U Bauner; B Wintersperger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.